Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-23

Clinical Trial Update: Safety of Anal Curcumin [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the safety of anal curcumin for anal intraepithelial neoplasia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Anal Curcumin (curcumin)

Snippet

Sponsor: Lisa Flowers | Conditions: Anal High Grade Squamous Intraepithelial Lesion | Phase 1 | Status: RECRUITING